Ariful Islam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ariful Islam has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Kalyani Pathak
Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, 786004, Assam, India
4 shared publications Aparoop Das
3 shared publications- Riya Saikia
Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, India
3 shared publications - Dibyajyoti Das
Center for Computational Drug Discovery, Pratiksha Institute of Pharmaceutical Sciences, Guwahati-781026, Assam,India
2 shared publications - Jon Jyoti Sahariah
Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh 786004, India
2 shared publications Pallab Pramanik
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 17 March 2026
- Published by Elsevier in Next Nanotechnology
- Vol. 9
Nanoparticles in the fight against antimicrobial challenges: A comprehensive review
- 17 March 2026
- Published by Elsevier in Next Nanotechnology
- Vol. 9
Top Cited PapersOpen AccessNanoparticles in the fight against antimicrobial challenges: A comprehensive review
- 22 August 2025
- Published by Elsevier in South African Journal of Botany
- Vol. 185, 540-564
Garcinia cowaRoxb.: A natural drugstore for traditional medicinal knowledge with multifaceted therapeutic applications
- 22 August 2025
- Published by Elsevier in South African Journal of Botany
- Vol. 185, 540-564
Garcinia cowaRoxb.: A natural drugstore for traditional medicinal knowledge with multifaceted therapeutic applications
- 7 August 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (6) , 1233-1247
Baicalein: Multiple Pharmacological Activities, Pharmacokinetics, and Clinical Trials
- 7 August 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (6) , 1233-1247
Baicalein: Multiple Pharmacological Activities, Pharmacokinetics, and Clinical Trials
- Open Access
- 12 June 2024
- Published by Elsevier in European Journal of Medicinal Chemistry Reports
- Vol. 12
Nanohybrid cerasomes: Advancements in targeted drug and gene delivery
- 12 June 2024
- Published by Elsevier in European Journal of Medicinal Chemistry Reports
- Vol. 12
Open AccessNanohybrid cerasomes: Advancements in targeted drug and gene delivery
- Open Access
- 29 December 2023
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 4 (6) , 1135-1167
3D printing in biomedicine: advancing personalized care through additive manufacturing
The integration of three-dimensional (3D) printing techniques into the domains of biomedical research and personalized medicine highlights the evolving paradigm shifts within contemporary healthcare. This technological advancement signifies potential breakthroughs in patient-specific therapeutic interventions and innovations. This systematic review offers a critical assessment of the existing literature, elucidating the present status, inherent challenges, and prospective avenues of 3D printing in augmenting biomedical applications and formulating tailored medical strategies. Based on an exhaustive literature analysis comprising empirical studies, case studies, and extensive reviews from the past decade, pivotal sectors including tissue engineering, prosthetic development, drug delivery systems, and customized medical apparatuses are delineated. The advent of 3D printing provides precision in the fabrication of patient-centric implants, bio-structures, and devices, thereby mitigating associated risks. Concurrently, it facilitates the ideation of individualized drug delivery paradigms to optimize therapeutic outcomes. Notwithstanding these advancements, issues concerning material biocompatibility, regulatory compliance, and the economic implications of avant-garde printing techniques persist. To fully harness the transformative potential of 3D printing in healthcare, collaborative endeavors amongst academicians, clinicians, industrial entities, and regulatory bodies are paramount. With continued research and innovation, 3D printing is poised to redefine the trajectories of biomedical science and patient-centric care. The paper aims to justify the research objective of whether to what extent the integration of 3D printing technology in biomedicine enhances patient-specific treatment and contributes to improved healthcare outcomes.
- 29 December 2023
- Published by Open Exploration Publishing in Exploration of Medicine
- Vol. 4 (6) , 1135-1167
Open Access3D printing in biomedicine: advancing personalized care through additive manufacturing
The integration of three-dimensional (3D) printing techniques into the domains of biomedical research and personalized medicine highlights the evolving paradigm shifts within contemporary healthcare. This technological advancement signifies potential breakthroughs in patient-specific therapeutic interventions and innovations. This systematic review offers a critical assessment of the existing literature, elucidating the present status, inherent challenges, and prospective avenues of 3D printing in augmenting biomedical applications and formulating tailored medical strategies. Based on an exhaustive literature analysis comprising empirical studies, case studies, and extensive reviews from the past decade, pivotal sectors including tissue engineering, prosthetic development, drug delivery systems, and customized medical apparatuses are delineated. The advent of 3D printing provides precision in the fabrication of patient-centric implants, bio-structures, and devices, thereby mitigating associated risks. Concurrently, it facilitates the ideation of individualized drug delivery paradigms to optimize therapeutic outcomes. Notwithstanding these advancements, issues concerning material biocompatibility, regulatory compliance, and the economic implications of avant-garde printing techniques persist. To fully harness the transformative potential of 3D printing in healthcare, collaborative endeavors amongst academicians, clinicians, industrial entities, and regulatory bodies are paramount. With continued research and innovation, 3D printing is poised to redefine the trajectories of biomedical science and patient-centric care. The paper aims to justify the research objective of whether to what extent the integration of 3D printing technology in biomedicine enhances patient-specific treatment and contributes to improved healthcare outcomes.